News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
France’s Ipsen Buys Biotech Firm Sterix
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Private French drugmaker Ipsen said on Thursday it had acquired a small British biotechnology firm prior to a possible initial public offering, in the latest sign of a pick-up in activity in the European sector.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase 1
IPO
Mergers & acquisitions
MORE ON THIS TOPIC
Manufacturing
Nascent US psychedelic therapy opportunity attracts overseas manufacturers
August 14, 2026
·
4 min read
·
Nick Paul Taylor
Phase 3
Taiho and Cullinan’s zipalertinib clears Phase 3, teeing up first-line competition
August 13, 2026
·
3 min read
·
Gabrielle Masson
Insights
The Italian inflection point: Clinical strength, culture and capital
August 13, 2026
·
1 min read
·
Jennifer C. Smith-Parker
Business
Behind the bell: Gearing up to go public
August 13, 2026
·
6 min read
·
Angela Gabriel
